CRISPR: The New Frontier of Biotechnology Innovation
CRISPR and CRISPR-Associated (Cas) Genes is a genome editing tool that enables the researchers to make changes in the DNA. CRISPR-Cas9 stands for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9. In recent years the CRISPR and CRISPR-Associated (Cas) Genes has gained lot of popularity as it offers it is cheaper, faster, accurate, and more efficient genome editing methods.
The CRISPR and CRISPR-associated (Cas) Genes market is anticipated to grow in the forecast, owing to the factors such as rising adoption of genome editing technique, growing adoption of CRISPR, and increasing prevalence of genetic disorders. Furthermore, increasing demand for drug discovery is likely to pose growth opportunities for the CRISPR and CRISPR-associated (Cas) Genes market to grow.
Download PDF Brochure @ Click Here
Product :
- Vector-based Cas,
- DNA-free Cas
Application :
- Genome Engineering,
- Disease models,
- Functional Genomics,
- Knockdown/activation,
- Others
End User :
- Biotechnology and Pharmaceutical Companies,
- Academic and Government Research Institutes,
- Contract Research Organizations
Dominated Players :
- Merck KGaA
- Addgene
- CRISPR THERAPEUTICS
- Thermo Fisher Scientific, Inc.
- Mirus Bio LLC
- Editas Medicine
- Takara Bio USA
- Horizon Discovery Group plc
- Dharmacon Inc
- Intellia Therapeutics, Inc.
Future Directions :
It’s amazing to see how much progress has been made in just five years, with the skyrocketing popularity of CRISPR echoing that of RNAi and iPS cells. Genome engineers continue to work to develop a highly specific, programmable platform well-suited for various biological and translational technologies. Biotechnology companies are exploring therapeutic applications of CRISPR to treat genetic disease, with the caveat that off-target editing risk must be made very low or nonexistent. Scientists continue to wrestle with the possibility of postnatal and germline editing, with the International Summit of Human Gene Editing convened in 2015 to discuss the ethics associated with CRISPR in agricultural and therapeutic applications.
Despite the ethical controversies surrounding non-research applications, it’s clear that CRISPR is a truly disruptive technology for basic research. The beauty of CRISPR is that it’s adaptable to almost any model system or biological topic, and you don’t need to be an expert to see results!
The report of 150 Pages analyzes factors affecting CRISPR and CRISPR-associated (Cas) Genes market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the CRISPR and CRISPR-associated (Cas) Genes market in these regions.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Ask For 150 Pages PDF of this study
References:
- theinsightpartners.com